Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects

NCT00779766 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6081

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Papillomavirus

Interventions

BIOLOGICAL: HPV GSK 580299 vaccine
BIOLOGICAL: Placebo control

Sponsor

GlaxoSmithKline